BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,559,000 | -37.9% | 775,254 | -9.2% | 0.03% | -37.2% |
| Q3 2016 | $16,996,000 | +53.5% | 854,055 | 0.0% | 0.04% | +53.6% |
| Q2 2016 | $11,069,000 | +101.3% | 854,055 | +45.2% | 0.03% | +100.0% |
| Q1 2016 | $5,500,000 | -10.3% | 588,207 | +94.5% | 0.01% | -6.7% |
| Q4 2015 | $6,131,000 | +68.8% | 302,489 | +21.0% | 0.02% | +66.7% |
| Q3 2015 | $3,633,000 | +13.9% | 250,000 | +66.7% | 0.01% | +12.5% |
| Q2 2015 | $3,191,000 | +175.3% | 150,000 | +200.0% | 0.01% | +166.7% |
| Q1 2015 | $1,159,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 918,000 | $11,328,000 | 4.35% |
| EMORY UNIVERSITY | 164,607 | $2,031,000 | 1.92% |
| Monashee Investment Management LLC | 160,000 | $1,974,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 210,260 | $2,595,000 | 0.65% |
| CORRADO ADVISORS, LLC | 83,622 | $1,032,000 | 0.59% |
| Foresite Capital Management II, LLC | 105,000 | $1,296,000 | 0.56% |
| Baker Brothers Advisors | 5,032,313 | $62,099,000 | 0.51% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $2,468,000 | 0.48% |
| Clearline Capital LP | 55,200 | $681,000 | 0.32% |
| LMR Partners LLP | 270,594 | $3,339,000 | 0.32% |